KIM CHRIS enters LIMINATUS PHARMA, INC. with 6.17M shares across direct and indirect positions
This filing by KIM CHRIS (Chief Executive Officer) establishes the baseline for all future Form 4 insider transaction reports at LIMINATUS PHARMA, INC..
Indirect
Filed: 4/30/2025ACC: 0001104659-25-042793
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2025
6.17M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
6.17M indirect
Non-Derivative Holdings1
Common Stock, par value $0.0001 per share
IndirectShares owned6.17M
Total
6.17M indirect6.17M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.0001 per share | 6.17M | Indirect |
| Total | 6.17M | 6.17M indirect |
Derivative Holdings0
No derivative holdings reported